Philips Respironics recalled 13,811 ventilators the company reworked or replaced after it pulled millions of them off the market in summer 2021. The devices — Trilogy 100, Trilogy 200, and Garbin Plus ...
The U.S. Food and Drug Administration (FDA) has ordered a software recall for a type of ventilator, for fear of "serious injuries or death." The ventilators—the Philips Respironics, Inc. Trilogy EVO, ...
SANTA CLARA, Calif., Sept. 13, 2017 /PRNewswire/ -- Based on its recent analysis of the home ventilation market, Frost & Sullivan recognizes Philips with the 2017 North American Home Ventilation ...
More than a year into the repair-and-replace program for the 5.5 million CPAP and BiPAP machines and other ventilators recalled by Philips since June 2021, the Dutch devicemaker has identified a pair ...
(RTTNews) - Philips Respironics, affiliated to Dutch consumer electronics giant, announced additional usage instructions for Trilogy Evo Ventilators related to use of in-line nebulizers. The company ...
The FDA cited Philips Healthcare ($PHG) subsidiary Philips Respironics with a Class 1 recall--the agency's most serious designation--for 600 of the company's Trilogy ...
Philips Respironics, a division of Philips Healthcare, has initiated a voluntary recall of its Trilogy Ventilator to address a potentially defective component on its power management board. Philips ...
Philips' Trilogy offer multiple ventilation modes, real time data sharing capabilities and a long battery life that allows patients to have a near normal quality of life. SANTA CLARA, California, Sept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback